Live Demonstration on Testing Methods for Optimal Safety and
Performance
The seminar ended with a live demonstration that highlighted the testing
methods performed during the annual certification, emphasizing the vital role
of regular maintenance in ensuring both safety and performance of the
laboratory equipment
URL: https://www.escolifesciences.com/news/optimizing-laboratory-safety-esco-malaysia-organized-choosing-the-right-engineering-control-laminar-flow-fume-hood-and-biosafety-cabinet-at-bahang-bay-hotel
CelCradle® + serves as a closed, single-use, self-contained primary
containment system for handling high-risk viruses, including those that have
not yet been classified but may pose significant pandemic threats, such as
potential "Disease X" viruses
(term used to describe a hypothetical, unknown pathogen that could cause a
global pandemic)
URL: https://www.escolifesciences.com/news/esco-debuts-new-member-of-the-tide-motion-bioreactor-family-designed-for-biosafety-level-34-virus-containment-to-boost-pandemic-preparedness-and-vaccine-self-sufficiency
As such, the company calls for equipment that will protect operators from spillages and guarantee their safety.
Esco manufactured and customized a VBE unit to address this safety concern.
The main chamber of the VBE is designed to house the spectrophotometer and its computer system; the latter is located at ...
URL: https://www.escolifesciences.com/news/robust-and-modular-esco-gb-ships-vbe-to-a-major-company-in-ireland
Comparing Steam-Activated and Chemical-Activated Carbon
While the two methods generally produce very similar activated carbon, there are some slight variations that can significantly impact filtration performance
URL: https://www.escolifesciences.com/news/quick-guide-to-carbon-filters
Esco would like to thank all our partners, clients, and collaborators for visiting us at the recent National Conference of Nuclear Medicine 2019 (NCNM 2019) at Avillion Port Dickson, Malaysia last July 30 - August 2
URL: https://www.escolifesciences.com/news/esco-joins-the-national-conference-of-nuclear-medicine-2019-malaysia
s range of isolators suitable for sterility testing includes the Containment Barrier Isolator (CBI), Aseptic Containment Isolator (ACTI), and the General Processing Platform Isolator (GPPI). The GPPI has been recommended for this client.
The GPPI features a unidirectional laminar airflow, user selectable positive or negative chamber pressures, single pass or ...
URL: https://www.escolifesciences.com/news/esco-gb-ltd-provides-a-sterility-testing-isolator-to-a-leading-global-pharmaceutical-company-in-europe
We hope that we were able to share some of our expertise with you.
img.secondary-image{
width: 80% !important;
position: relative;
left: 50%;
transform: translateX(-50%);
}
.article-video{
width: 70% !important;
margin: auto !important;
}
/* Extra small devices (phones, 600px and down) */
@media only screen and (max-width: 600px) {
img.secondary-image{ ...
URL: https://www.escolifesciences.com/news/esco-raises-biosafety-awareness-in-penang
The Top Employer Brand Award was given to the companies that scored above national benchmarks based on the companies’ capacity to engage employees, undertand their values and develop meaningful human resource practices.
Esco joins other companies - GRAB, SATS, Maybank, MindChamps, City Developments Limited, Dormakaba, PAP Community Foundation, and Rohei ...
URL: https://www.escolifesciences.com/news/esco-recognized-as-top-employer-brand-at-influential-brands-2018-ceo-asia-summit
Given that Wuhan Bio-Raid is one of the leading CAR-T companies across China, we are excited to further our viral vectors development capability in cGMP manufacturing suites executed with the expansive scientific resources and expertise to rapidly establish a reliable commercial supply for the most difficult to manufacture CAR-T therapies,&rdquo
URL: https://www.escolifesciences.com/news/esco-aster-and-wuhan-bio-raid-biotechnology-establish-memorandum-of-understanding-for-lentiviral-vector-platform-to-support-car-t-pipeline-in-china
Esco Group announced today that it has reached an agreement to acquire the remaining shares in AT Medical UAB, an Esco Ventures portfolio company. AT Medical UAB is the developer of innovative IVF medical devices whose products are currently distributed by Esco under the Esco Medical brand. The transaction is ...
URL: https://www.escolifesciences.com/news/esco-group-to-acquire-at-medical-uab
